Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 18
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Alan Davis – Psychedelic Research and Patient Safety at Ohio State...
Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices
Germany Establishes EU’s First Psilocybin Compassionate Access Program
Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices
Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness,...
William Leonard Pickard interviews Bryan Hubbard about the new policy frontier...
Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice;...
June 2025 Psychedelic Patent Update
Alan Davis – Psychedelic Research and Patient Safety at Ohio State...
Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Plasticity, Psychotherapy,...
Load more